Provider
QP37-24 Update for New-to-Market Medical Drugs: atidarsagene autotemcel, crovalimab, and fidanacogene eleparvovec
Program effective Date: May 08, 2024
Documents & Forms Results
Displaying 1451 - 1460 of 3165 results
Provider
QP39-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2024
Program effective Date: May 08, 2024
Provider
QP40-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2024
Program effective Date: May 08, 2024
Provider
QP43-24 MHCP Pharmacy Benefit Exclusion for Alyglo™ and Lenmeldy™
Program effective Date: May 08, 2024
Provider
QP42-24 Commercial Pharmacy Benefit Exclusion for Lenmeldy™
Program effective Date: May 08, 2024
Provider
QP41-24 Commercial Pharmacy Benefit Exclusion for Select Medications
Program effective Date: May 08, 2024
Provider
P32-24 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Program effective Date: May 01, 2024
Provider
P31-24 2024 Renewal Changes Summary for Blue Plus Referral Health Professional Providers
Program effective Date: May 01, 2024
Provider
P2R1-24 New 2024 Practitioner Credentialing Requirements Delayed Indefinitely
Program effective Date: May 01, 2024
Provider
P29-24 2024 Renewal Changes Summary for Suppliers of Durable Medical Equipment (DME)
Program effective Date: May 01, 2024